China Vanke Co.,Ltd.
000002
Merit Interactive
300766
Zhejiang Orient Financial Holdings Group
600120
4
Cambricon
688256
5
Kweichow Moutai
600519
CN Stock MarketDetailed Quotes
300858 Beijing Scitop Bio-tech
- 13.60
- +0.05+0.37%
Market Closed Jan 27 15:00 CST
3.58BMarket Cap38.64P/E (TTM)
14.06High13.45Low52.95KlotVolume13.48Open13.55Pre Close72.57MTurnover2.73%Turnover Ratio38.31P/E (Static)263.50MShares19.9752wk High2.03P/B2.64BFloat Cap12.6652wk Low16.26Limit Up193.76MShs Float37.15Historical High10.84Limit Down4.50%Amplitude10.53Historical Low0.15Dividend TTM13.70Avg Price22.51KlotAsk1.10%Div YieldTTM100Lot Size28.53KlotBid
Beijing Scitop Bio-tech News
Ketuo Biotech: First Venture Securities Underwriting and Sponsorship Co., Ltd. on the 2024 annual on-site inspection report of Beijing Ketuo Hengtong Biotechnology Co., Ltd.
Ketuo Biotech: First Venture Securities Underwriting and Sponsorship Co., Ltd. report on the 2024 continuous supervision and training of Beijing Ketuo Hengtong Biotechnology Co., Ltd.
Ketuo Biotech: Announcement of Resolutions of the 11th Meeting of the Third Board of Directors
Cotuo Biotech: Articles of Association (October 2024)
Cotuo Biotech: Announcement of Resolutions of the 10th Meeting of the 3rd Board of Supervisors
Ketuo Biotech: First Venture Securities Underwriting and Sponsorship Co., Ltd. opinion on Beijing Ketuo Hengtong Biotechnology Co., Ltd. turning part of the raised capital loans into capital increases for wholly-owned subsidiaries
Ketuo Biotech: Announcement of Resolutions of the 10th Meeting of the 3rd Board of Directors
Ketuo Biotech: Announcement on Obtaining Invention Patent Certificates and Utility Model Patent Certificates
Ketuo Biotech: First Venture Securities Underwriting and Sponsorship Co., Ltd. report on the 2024 semi-annual continuous supervision and follow-up report of Beijing Ketuo Hengtong Biotechnology Co., Ltd.
Beijing Scitop Bio-tech: The Rules for the Ownership and Changes of the Shares Held by Directors, Supervisors and Senior Management Personnel of the Company (August 2024)
Beijing Scitop Bio-tech: Announcement of the Supervisory Board's resolution.
Beijing Scitop Bio-tech: First Capital Securities Underwriting and Sponsorship Co., Ltd.'s verification opinion on the use of raised funds by Beijing Ketai Hengtong Biotechnology Co., Ltd. to increase the capital of its wholly-owned subsidiary through relevant creditor's rights.
Beijing Scitop Bio-tech: Special report on the storage and use of funds raised in the first half of 2024.
Beijing Scitop Bio-tech: First Capital Securities Underwriting and Sponsorship Co., Ltd.'s internal investment structure verification opinion on the adjustment of part of the investment projects of Beijing Kethor Hengtong Biotechnology Co., Ltd.
Beijing Scitop Bio-tech: Announcement regarding the use of idle funds for cash management.
Beijing Scitop Bio-tech: First Capital Securities Co., Ltd.'s underwriting and sponsorship verification opinion regarding Beijing Kaituo Hengtong Biotechnology Co., Ltd.'s use of idle proprietary funds for cash management.
Beijing Scitop Bio-tech: First Capital Securities Underwriting Sponsorship Co., Ltd.'s Verification Opinion on Beijing Peking Hengtong Biotechnology Co., Ltd.'s Use of Unused Fund Raising Funds for Cash / Money Market Management.
Beijing Scitop Bio-tech: Board of directors resolution announcement.
Beijing Scitop Bio-tech: Announcement regarding the obtainment of invention patent and utility model patent certificates.
Beijing Scitop Bio-tech: Announcement of Resolutions of the Eighth Meeting of the Third Board of Supervisors